Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826665 · ClinicalTrials.gov registry record
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
A clinical trial of Persistent Atrial Fibrillation, sponsored by Kansas City Heart Rhythm Research Foundation.
- Recruiting
- Registry status
- 200
- Enrollment target
- 4
- Study locations
NCT05826665 is a study of Persistent Atrial Fibrillation that is actively recruiting participants, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 200 participants, below the 1,247-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (84% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT05826665, a study of Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Kansas City Heart Rhythm Research Foundation.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard FDA cleared catheters and devices. This study aims to examine the impact of the STAR Apollo Mapping System on procedural and acute outcomes in a multicenter observational study.
Conditions Studied
Interventions
- OTHER Persistent AF ablation assisted with the STAR Apollo Mapping System
Study Locations (4)
Kansas
- Kansas City Heart Rhythm Institute - Roe Clinic - Overland Park
- Overland Park Regional Medical Center - Overland Park
Arkansas
- St.Bernards Medical Center - Jonesboro
Florida
- Sarasota Medical Center - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05826665
The ClinicalTrials.gov registry entry for NCT05826665 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,247-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (84% lower). The listed sponsor is Kansas City Heart Rhythm Research Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Persistent AF ablation assisted with the STAR Apollo Mapping System is the first listed.
NCT05826665 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Kansas, Arkansas, Florida.
Frequently Asked Questions
What is clinical trial NCT05826665 about?
NCT05826665 is a clinical study titled "Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System". STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining ...
What is the current status of trial NCT05826665?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-10-02. Estimated completion is 2025-07-31.
What conditions does trial NCT05826665 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT05826665?
The interventions under investigation include: Persistent AF ablation assisted with the STAR Apollo Mapping System (OTHER).
Who is sponsoring clinical trial NCT05826665?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05826665 being conducted?
This trial has 4 study locations across Arkansas, Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
SPHERE Per-AF Post-Approval Study
RECRUITING
-
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
RECRUITING · Phase 4
-
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.